Published in Gastroenterology on May 01, 2007
Ghrelin and Gastric Emptying in Children With Functional Dyspepsia (GHR) | NCT01591174
Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) (2008) 3.97
Environmental causes of esophageal cancer. Gastroenterol Clin North Am (2009) 2.80
Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab (2008) 2.05
The lipid messenger OEA links dietary fat intake to satiety. Cell Metab (2008) 2.01
Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology (2010) 1.96
Central control of body weight and appetite. J Clin Endocrinol Metab (2008) 1.91
Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology (2013) 1.70
Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology (2009) 1.66
Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology (2008) 1.63
Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. J Physiol (2009) 1.52
Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol (2007) 1.48
Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling. Diabetes (2012) 1.29
Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc (2010) 1.28
Associations of dietary intake and physical activity with sleep disordered breathing in the Apnea Positive Pressure Long-Term Efficacy Study (APPLES). J Clin Sleep Med (2008) 1.19
Dietary resistant starch increases hypothalamic POMC expression in rats. Obesity (Silver Spring) (2008) 1.16
An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity (Silver Spring) (2008) 1.13
Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes (Lond) (2010) 1.13
Ghrelin for cachexia. J Cachexia Sarcopenia Muscle (2010) 1.12
A cluster of gustducin-expressing cells in the mouse stomach associated with two distinct populations of enteroendocrine cells. Histochem Cell Biol (2007) 1.10
Vertical sleeve gastrectomy improves glucose and lipid metabolism and delays diabetes onset in UCD-T2DM rats. Endocrinology (2012) 1.09
Expression of nesfatin-1/NUCB2 in rodent digestive system. World J Gastroenterol (2010) 1.05
Peptides and food intake. Front Endocrinol (Lausanne) (2014) 1.01
Bariatric surgery for extreme adolescent obesity: indications, outcomes, and physiologic effects on the gut-brain axis. Pathophysiology (2008) 1.01
Arx is required for normal enteroendocrine cell development in mice and humans. Dev Biol (2012) 0.98
Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells. Adv Nutr (2012) 0.97
Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats. Diabetes (2010) 0.96
What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia? J Neurogastroenterol Motil (2011) 0.94
Neuroendocrine circuits governing energy balance and stress regulation: functional overlap and therapeutic implications. Cell Metab (2014) 0.92
Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. JPEN J Parenter Enteral Nutr (2011) 0.91
Sensitivity to the satiating effects of exendin 4 is decreased in obesity-prone Osborne-Mendel rats compared to obesity-resistant S5B/Pl rats. Int J Obes (Lond) (2010) 0.91
Nesfatin-1 inhibits gastric acid secretion via a central vagal mechanism in rats. Am J Physiol Gastrointest Liver Physiol (2012) 0.90
The neurocognitive connection between physical activity and eating behaviour. Obes Rev (2011) 0.89
Ghrelin and functional dyspepsia. Int J Pept (2010) 0.88
Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia. Am J Med Genet A (2014) 0.88
Long-term dietary restriction influences plasma ghrelin and GOAT mRNA level in rats. Physiol Behav (2010) 0.87
Neuroimaging, gut peptides and obesity: novel studies of the neurobiology of appetite. J Neuroendocrinol (2010) 0.87
Influence of acute exposure to high altitude on basal and postprandial plasma levels of gastroenteropancreatic peptides. PLoS One (2012) 0.87
The intestinal peptide transporter PEPT1 is involved in food intake regulation in mice fed a high-protein diet. PLoS One (2011) 0.86
Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesity. Diabetes (2008) 0.86
Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity. Endocrinology (2009) 0.85
Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose. Nutr J (2009) 0.85
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice. Genes Nutr (2009) 0.85
Helicobacter pylori protection against reflux esophagitis. Dig Dis Sci (2012) 0.85
The Bitter Taste Receptor Agonist Quinine Reduces Calorie Intake and Increases the Postprandial Release of Cholecystokinin in Healthy Subjects. J Neurogastroenterol Motil (2015) 0.83
Postprandial total ghrelin suppression is modulated by melanocortin signaling in humans. J Clin Endocrinol Metab (2013) 0.82
Short-term aerobic exercise training increases postprandial pancreatic polypeptide but not peptide YY concentrations in obese individuals. Int J Obes (Lond) (2013) 0.82
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry (2016) 0.82
A Community-Based Exercise and Support Group Program in African-American Breast Cancer Survivors (ABCs). J Phys Ther Health Promot (2013) 0.82
Bariatric embolization of the gastric arteries for the treatment of obesity. J Vasc Interv Radiol (2015) 0.81
Metformin increases plasma ghrelin in Type 2 diabetes. Br J Clin Pharmacol (2009) 0.80
The Gut-Brain Axis: The Missing Link in Depression. Clin Psychopharmacol Neurosci (2015) 0.80
Peptide YY and ghrelin predict craving and risk for relapse in abstinent smokers. Psychoneuroendocrinology (2014) 0.80
Increasing doses of fiber do not influence short-term satiety or food intake and are inconsistently linked to gut hormone levels. Food Nutr Res (2010) 0.80
Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence? Int J Obes (Lond) (2015) 0.79
Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents. Biochim Biophys Acta (2015) 0.79
Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity. Mol Pharm (2012) 0.79
Molecular signatures reveal circadian clocks may orchestrate the homeorhetic response to lactation. PLoS One (2009) 0.79
Reconstruction-dependent recovery from anorexia and time-related recovery of regulatory ghrelin system in gastrectomized rats. Int J Pept (2010) 0.78
Peripheral signals mediate the beneficial effects of gastric surgery in obesity. Gastroenterol Res Pract (2015) 0.78
Adhesion GPCRs are widely expressed throughout the subsections of the gastrointestinal tract. BMC Gastroenterol (2012) 0.78
Emerging markers of cachexia predict survival in cancer patients. BMC Cancer (2014) 0.78
Psychobiology of purging disorder: reduction in circulating leptin levels in purging disorder in comparison with controls. Int J Eat Disord (2010) 0.78
Regulation of appetite to treat obesity. Expert Rev Clin Pharmacol (2011) 0.77
Decreased luteinizing hormone pulse frequency is associated with elevated 24-hour ghrelin after calorie restriction and exercise in premenopausal women. Am J Physiol Endocrinol Metab (2012) 0.77
Modulatory role of PYY in transport and metabolism of cholesterol in intestinal epithelial cells. PLoS One (2012) 0.77
Identification of the porcine G protein-coupled receptor 41 and 43 genes and their expression pattern in different tissues and development stages. PLoS One (2014) 0.77
New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders. World J Diabetes (2015) 0.76
Evaluation and treatment of gastric stimulator failure in patients with gastroparesis. Surg Innov (2013) 0.76
Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity. Expert Rev Endocrinol Metab (2010) 0.76
Loss of pons-to-hypothalamic white matter tracks in brainstem obesity. Int J Obes (Lond) (2014) 0.76
Current status of intragastric balloon for obesity treatment. World J Gastroenterol (2016) 0.76
Ghrelin, food intake, and botanical extracts: A Review. Avicenna J Phytomed (2015) 0.75
Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high-fat diet-induced obesity. Mol Nutr Food Res (2016) 0.75
Comparison of Weight Loss, Ghrelin, and Leptin Hormones After Ligation of Left Gastric Artery and Sleeve Gastrectomy in a Rat Model. Med Sci Monit (2017) 0.75
Voluntary consumption of ethyl oleate reduces food intake and body weight in rats. Physiol Behav (2007) 0.75
Peptide hormones and lipopeptides: from self-assembly to therapeutic applications. J Pept Sci (2017) 0.75
(-)-Epigallocatechin-3-gallate induces secretion of anorexigenic gut hormones. J Clin Biochem Nutr (2015) 0.75
Modulation of the Bitter Taste to Reduce Calorie Intake. J Neurogastroenterol Motil (2015) 0.75
Physiology of weight loss surgery. Surg Clin North Am (2011) 0.75
The effects of ghrelin on energy balance and psychomotor activity in a goldfish model: an overview. Int J Pept (2011) 0.75
Two ghrelin receptor agonists for adults with malnutrition: a systematic review and meta-analysis. Nutr J (2016) 0.75
Effects of nicotine on homeostatic and hedonic components of food intake. J Endocrinol (2017) 0.75
Protein Digestion-Derived Peptides and the Peripheral Regulation of Food Intake. Front Endocrinol (Lausanne) (2017) 0.75
Appetite responses to high-fat meals or diets of varying fatty acid composition: a comprehensive review. Eur J Clin Nutr (2017) 0.75
Psychological and Neurobiological Correlates of Food Addiction. Int Rev Neurobiol (2016) 0.75
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 7.36
Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab (2001) 6.41
A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 6.03
Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet (1987) 4.97
The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology (2000) 3.80
Ghrelin causes hyperphagia and obesity in rats. Diabetes (2001) 3.62
A glucagonoma syndrome. Lancet (1974) 3.56
Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36
Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet (1973) 3.22
Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet (1976) 3.08
Distribution and release of human pancreatic polypeptide. Gut (1976) 3.02
Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology (2005) 2.80
Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut (1971) 2.75
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Neuron-specific enolase is produced by neuroendocrine tumours. Lancet (1981) 2.63
Breast vs bottle: endocrine responses are different with formula feeding. Lancet (1980) 2.52
Measurement of fasting and postprandial plasma VIP in man. Gut (1978) 2.48
Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 2.48
Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child (1981) 2.36
Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol (2004) 2.27
Gut-hormone profile in coeliac disease. Lancet (1978) 2.25
Saturation of fat and cholecystokinin release: implications for pancreatic carcinogenesis. Lancet (1989) 2.25
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab (2001) 2.24
Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol (2001) 2.20
Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology (1998) 2.14
Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet (1976) 2.13
The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. Gut (1984) 2.11
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet (1975) 2.04
The role of the sympathetic innervation in the control of plasma glucagon concentration in the calf. J Physiol (1973) 2.01
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist. Br Med J (Clin Res Ed) (1983) 1.93
Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg (2006) 1.91
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes (1999) 1.90
Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest (1997) 1.89
Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J Neurosci (1984) 1.88
Effects of stimulation of the chorda tympani in bursts on submaxillary responses in the cat. J Physiol (1982) 1.84
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. Am J Pathol (1990) 1.80
Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet (1977) 1.75
Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab (2000) 1.75
Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology (1997) 1.74
The effect of truncal and selective vagotomy on the release of pancreatic glucagon, insulin and enteroglucagon. Br J Surg (1974) 1.73
Bombesin-like immunoreactivity in the lung. Nature (1978) 1.73
Localization of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab (1996) 1.72
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab (2003) 1.71
Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology (1980) 1.70
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
An enteroglucagon tumour. Gut (1972) 1.69
Mechanism of pancreatic polypeptide release in man. Lancet (1977) 1.68
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 1.68
Motilin and the interdigestive migrating motor complex in man. Dig Dis Sci (1979) 1.67
A radioimmunoassay for neurotensin in human plasma. J Endocrinol (1979) 1.66
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest (1995) 1.66
Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology (1999) 1.65
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab (2002) 1.65
Vasoactive intestinal peptide in relation to atropine resistant vasodilatation in the submaxillary gland of the cat. J Physiol (1980) 1.62
Changing trends in the management of phaeochromocytoma. Br J Surg (1998) 1.62
Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) (2005) 1.62
Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut (1996) 1.60
Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia (1990) 1.58
The role of the autonomic innervation in the control of glucagon release during hypoglycaemia in the calf. J Physiol (1974) 1.58
Effect of neurotensin on gastric function in man. Lancet (1980) 1.55
Calcitonin gene-related peptide in cardiovascular tissues of the rat. Neuroscience (1985) 1.55
Endocrine responses to insulin hypoglycaemia in the young calf. J Physiol (1975) 1.52
Release of glucagon, induced by stress. Q J Exp Physiol Cogn Med Sci (1973) 1.51
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut (2005) 1.49
Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci U S A (1984) 1.49
Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry. Nature (1977) 1.47
Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis. Arch Dis Child (1992) 1.46
Lithium intoxication. BMJ (1991) 1.45
Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A (1989) 1.44
Pancreatic cholera due to production of gastric inhibitory polypeptide. Lancet (1972) 1.44
Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastroenterology (1985) 1.44
New autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides. Lancet (1991) 1.43
Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab (2004) 1.43
Current problems in the measurement of gastrin release. A reproducible measure of physiological gastrin release. Postgrad Med J (1976) 1.42
Effect of calcitonin on gastrointestinal regulatory peptides in man. Clin Endocrinol (Oxf) (1985) 1.42
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab (1981) 1.42
Plasma motilin, gastrin, and enteroglucagon and feeding in the human newborn. Arch Dis Child (1980) 1.42
Pleural involvement in the carcinoid syndrome. Q J Med (1993) 1.42
Hormones of the gastrointestinal tract. Br Med Bull (1974) 1.41
Measurement of human plasma motilin. Scand J Gastroenterol Suppl (1976) 1.41
Hormonal and metabolic responses to cholecystectomy: comparison of extradural somatostatin and diamorphine. Br J Anaesth (1989) 1.40
Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet (1978) 1.39
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry (1989) 1.38
Ketoacidosis in pancreatectomized man. N Engl J Med (1977) 1.38
The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest (2000) 1.37
Preliminary report: role of peptide YY in defence against diarrhoea. Lancet (1990) 1.37
Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol (1985) 1.37
Alterations of sucrose preference after Roux-en-Y gastric bypass. Physiol Behav (2011) 1.37
The newer gut hormones. Cellular sources, physiology, pathology, and clinical aspects. Gastroenterology (1977) 1.36
The effect of altered luminal nutrition on cellular proliferation and plasma concentrations of enteroglucagon and gastrin after small bowel resection in the rat. Br J Surg (1982) 1.36
Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet (1984) 1.34
Formation of endothelin by cultured airway epithelial cells. FEBS Lett (1989) 1.34
Metabolic and endocrine events at the time of the first feed of human milk in preterm and term infants. Arch Dis Child (1978) 1.32